about
In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculiCompetitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidPharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.The new fluoroquinolones: A critical reviewMeningitis in a Chinese adult patient caused by Mycoplasma hominis: a rare infection and literature review.Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model.Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.Levofloxacin and sparfloxacin: new quinolone antibiotics.Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters.Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.Disposition kinetics of sparfloxacin in healthy, hepatopathic, and nephropathic conditions in chicken after single intravenous administration.Design and evaluation of dental films of PEGylated rosin derivatives containing sparfloxacin for periodontitis.Optimization, Validation and Application of a Capillary Zone Electrophoresis Method for the Assay of Sparfloxacin in Pharmaceutical FormulationA Simple High-performance Liquid Chromatographic Assay for Sparfloxacin in Human Plasma
P2860
Q28368389-5072F374-24BD-4716-85F8-0B679DBECB65Q33668223-303FF526-07CB-468D-9D3C-CFCA9D34C977Q35123325-29170094-08CF-4FB1-B1E5-CF3CD2F132C5Q35649595-2FC62846-ACF7-48EF-99EA-C782C34F522CQ36160824-CB6366BE-0C47-40CD-A4BB-6FC042E4E163Q36742821-C7558138-FC92-493A-8B8B-6D5F5883902BQ37333151-D9094E7E-38D1-4C7B-AFEF-35CE3D8AEBEAQ37881273-BA349DFC-E712-48EC-8E93-4F081AAF4CEFQ37995676-5FE2F057-13B7-4AAC-BE1E-8CDC5CB3987BQ39557763-C18264C3-B6AB-45D0-9C9F-7F4C5D2DC885Q39784655-62CF6FCA-F54A-41C7-BE0B-B69DD56DC53CQ40269614-98247CEC-5015-4183-96FD-6AB4FB3E5941Q49582210-5DB91DF2-BE80-4F41-BD8F-8B49D6BA75B5Q58129858-17B59316-9667-4C3F-9D45-F5FF57DD187DQ58260197-423926C5-17AF-4D3E-A87E-2C9987F9D14F
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Clinical pharmacokinetics of sparfloxacin
@ast
Clinical pharmacokinetics of sparfloxacin
@en
Clinical pharmacokinetics of sparfloxacin
@nl
type
label
Clinical pharmacokinetics of sparfloxacin
@ast
Clinical pharmacokinetics of sparfloxacin
@en
Clinical pharmacokinetics of sparfloxacin
@nl
prefLabel
Clinical pharmacokinetics of sparfloxacin
@ast
Clinical pharmacokinetics of sparfloxacin
@en
Clinical pharmacokinetics of sparfloxacin
@nl
P2093
P3181
P1476
Clinical pharmacokinetics of sparfloxacin
@en
P2093
P304
P3181
P356
10.2165/00003088-199325050-00002
P407
P577
1993-11-01T00:00:00Z
P6179
1017320828